Publisher's Synopsis
The world is grappling with increasing rates of obesity (an increase from 650 million people to 2 billion people by 2035) and type 2 diabetes-T2D (an increase from 500 million people to 1.3 billion people by 2050); therefore, they are among the highest public health and scientific priorities and demand a prompt and thorough multidisciplinary approach. Thus, as the field of diabetology is one that is full of novelties and includes numerous innovations in management and therapy, we deliberately chose to discuss those that are currently improving or will improve how management is conducted, which was carried out in our reprint, titled "Management of type 2 diabetes-Current insights and future directions". An overview of the current evidence and insights into novelties in the field of diabetology (co)management are presented, such as models for predicting/detecting dysglycemia, digital solutions to improve medication adherence, aspects relating to psychology and quality of life, predictors of therapeutic success, the principles of therapy individualization, pharmacoeconomic and reimbursement obstacles and solutions, as well as teachings on the pharmacological management of T2D and the principles of evidence-based medicine. We hope that our publication will draw the attention of readers, patients, students, scientists, clinicians, and policymakers, and that it will result in an overall improvement in the quality of the multidisciplinary care and management of diabetes.
